focus -WSS

focus

author：fashion 2025-10-01 21:37:13 - browse：88962

The FDA building -- First Opinion coverage from STAT — Adobe

The clearance of a first-of-its-kind cancer treatment made by Amgen is on shakier ground following a Food and Drug Administration advisory committee meeting Thursday.

Regulatory advisers voted 10-2 that the data on the company’s drug Lumakras, a treatment for lung cancer, could not be properly assessed. Lumakras targets a specific mutation to a protein called KRAS, which is one of the most common genetic mutations in cancer.

The vote comes as Amgen is hoping to convert a conditional approval for the drug to a full approval based on a 345-person study called CodeBreaK 200, in which Lumakras met the primary endpoint, delaying tumor growth approximately five weeks longer than the standard of care medication, docetaxel. The drug didn’t extend patients’ overall survival.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： STAT Madness 2024: Meet the contenders

knowledge

WSS

These geoengineering technologies could help combat the climate crisis, scientists say

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

PhRMA sues HHS over Medicare drug price negotiation

CDC advisory group OKs chikungunya vaccine

NEJM study measures Covid brain fog, impact on IQ

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Wikipedia

focus

focus

Drug repurposing or repositioning? The language matters

Brain 'hot spot' may explain why African Americans feel greater pain

The cancer drug shortage isn’t new — and neither are the solutions

Van's Gluten Free Original Waffles recalled for possible wheat allergen

23andMe had bad news about my health. I wish a person had delivered it

'Vaccine

State Dept. review finds Biden bears some blame for Afghanistan failures

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Supreme Court strikes down use of affirmative action

4th of July breaks record for highest global temperature ever measured

entertainment

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Redefining sustainability for the pharmaceutical industry

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Listen: PBM conflicts, RSV vaccines, & the future of flu season

Redefining sustainability for the pharmaceutical industry

Brain 'hot spot' may explain why African Americans feel greater pain

focus

knowledge

focus

hotspot